Qartemi: India’s Affordable CAR-T Therapy for Blood Cancer
India presents Qartemi, a profitable car-t cell therapy for non Hodgkin lymphoma of B cells, offered by New Hope with a success rate of 83.3%. India presents a new CAR-T cell therapy To treat non Hodgkin lymphoma (B-NHL). NHL is a type of Blood cancer That affects B cells. This new treatment approach is called … Read more